印度和中国正在生产畅销减肥药的廉价版本。 - Suppr

Suppr

超能文献

Cheaper versions of blockbuster obesity drugs are being created in India and China.

作者信息

Mallapaty Smriti

出版信息

Nature. 2024 Jun;630(8018):797-798. doi: 10.1038/d41586-024-02044-x.

DOI:10.1038/d41586-024-02044-x

PMID:38898254

Abstract

摘要

相似文献

Cheaper versions of blockbuster obesity drugs are being created in India and China.

Nature. 2024 Jun;630(8018):797-798. doi: 10.1038/d41586-024-02044-x.

Orlistat over the counter.

BMJ. 2007 Dec 8;335(7631):1163-4. doi: 10.1136/bmj.39385.347049.80. Epub 2007 Nov 15.

Orlistat over the counter: People should be free to spend their money as they wish.

BMJ. 2008 Jan 5;336(7634):7. doi: 10.1136/bmj.39435.502801.3A.

The sale of weight-loss supplements on the Internet: A lurking health care crisis waiting to strike.

Heart Rhythm. 2009 May;6(5):663-4. doi: 10.1016/j.hrthm.2009.03.001. Epub 2009 Mar 3.

ABC of obesity. Management: part II--drugs.

BMJ. 2006 Oct 14;333(7572):794-7. doi: 10.1136/bmj.333.7572.794.

Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs.

Recent Pat CNS Drug Discov. 2014;9(2):122-40. doi: 10.2174/1574889809666140613115426.

[Drug therapy of obesity--from bitter experiences to future possibilities].

Lakartidningen. 2000 Apr 5;97(14):1726-8.

Are newer drugs better drugs?

Obes Rev. 2003 May;4(2):75. doi: 10.1046/j.1467-789x.2003.00097.x.

Obesity therapeutics in the shadows: editorial.

Am J Ther. 2004 May-Jun;11(3):155. doi: 10.1097/00045391-200405000-00001.

Anti-obesity drugs: are they worth it?

Future Med Chem. 2011 Mar;3(3):267-9. doi: 10.4155/fmc.11.5.

引用本文的文献

Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.

Lancet. 2025 Mar 8;405(10481):813-838. doi: 10.1016/S0140-6736(25)00355-1. Epub 2025 Mar 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cheaper versions of blockbuster obesity drugs are being created in India and China.

Nature. 2024 Jun;630(8018):797-798. doi: 10.1038/d41586-024-02044-x.

Orlistat over the counter.

BMJ. 2007 Dec 8;335(7631):1163-4. doi: 10.1136/bmj.39385.347049.80. Epub 2007 Nov 15.

Orlistat over the counter: People should be free to spend their money as they wish.

BMJ. 2008 Jan 5;336(7634):7. doi: 10.1136/bmj.39435.502801.3A.

The sale of weight-loss supplements on the Internet: A lurking health care crisis waiting to strike.

Heart Rhythm. 2009 May;6(5):663-4. doi: 10.1016/j.hrthm.2009.03.001. Epub 2009 Mar 3.

ABC of obesity. Management: part II--drugs.

BMJ. 2006 Oct 14;333(7572):794-7. doi: 10.1136/bmj.333.7572.794.

Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs.

Recent Pat CNS Drug Discov. 2014;9(2):122-40. doi: 10.2174/1574889809666140613115426.

[Drug therapy of obesity--from bitter experiences to future possibilities].

Lakartidningen. 2000 Apr 5;97(14):1726-8.

Are newer drugs better drugs?

Obes Rev. 2003 May;4(2):75. doi: 10.1046/j.1467-789x.2003.00097.x.

Obesity therapeutics in the shadows: editorial.

Am J Ther. 2004 May-Jun;11(3):155. doi: 10.1097/00045391-200405000-00001.

Anti-obesity drugs: are they worth it?

Future Med Chem. 2011 Mar;3(3):267-9. doi: 10.4155/fmc.11.5.

引用本文的文献

Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.

Lancet. 2025 Mar 8;405(10481):813-838. doi: 10.1016/S0140-6736(25)00355-1. Epub 2025 Mar 3.